Alicapistat (ABT-957) (Synonyms: ABT-957) |
Catalog No.GC33743 |
Alicapistat (ABT-957) (ABT-957) est un inhibiteur sélectif actif par voie orale des calpaÏnes humaines 1 et 2 pour l'application potentielle de la maladie d'Alzheimer (MA).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1254698-46-8
Sample solution is provided at 25 µL, 10mM.
Alicapistat (ABT-957) is an orally active selective inhibitor of human calpains 1 and 2 for the potential use in the treatment of Alzheimer's disease (AD).
[1]. Lon HK, et al. Pharmacokinetics, Safety, Tolerability, and Pharmacodynamics of Alicapistat, a Selective Inhibitor of Human Calpains 1 and 2 for the Treatment of Alzheimer Disease: An Overview of Phase 1 Studies. Clin Pharmacol Drug Dev. 2018 Jul 27.
Average Rating: 5
(Based on Reviews and 13 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *